STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that it will release ...

Staar Surgical CEO Stephen Farrell and Board of Directors Chair Elizabeth Yeu have stepped down from the company’s board, effective immediately.

Mizuho has downgraded STAAR Surgical (NASDAQ:STAA) to neutral from outperform, citing a slowdown in sales of the company's ...

Preliminary net sales of $94.7 million, up 6.9% compared to $88.6 million in the prior year period. Preliminary net sales included $25.9 million related to the previously disclosed December 2024 ICL ...

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, ...

LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, ...

STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, announced that based on ...

Deferring to Alcon to Solicit Proxies for the Proposed Merger Will Not Relieve STAAR’s Board of Its Credibility Deficit with Shareholders HONG KONG--(BUSINESS WIRE)-- Yunqi Capital Limited (together ...